news

Focus of the two sessions: encouraging domestic medical devices and other biological products to replace imports


Release time:

2021-03-09

Medical devices have an important position in the pharmaceutical industry, not only with a huge market size, which has exceeded 500 billion yuan in 2018 alone, but also with a fast growth rate. Data from the China Medical Device Industry Development Report shows that the annual growth rate of the medical device industry has been higher than the average among the eight sub-industries of the pharmaceutical industry counted by the Ministry of Industry and Information Technology from 2013 to 2016. With the development of medical and health care in China, there is still very much room for development in the medical device industry.

  Medical devices have an important position in the pharmaceutical industry, not only with a huge market size, which has exceeded 500 billion yuan in 2018 alone, but also with a fast growth rate. Data from the China Medical Device Industry Development Report shows that the annual growth rate of the medical device industry has been higher than the average among the eight sub-industries of the pharmaceutical industry counted by the Ministry of Industry and Information Technology from 2013 to 2016. With the development of medical and health care in China, there is still very much room for development in the medical device industry.

  However, the same as the analysis instrument industry, the medical device industry also faces the problem that although the domestic market scale is huge, the high-end market has been monopolized by imported products for a long time. In the context of the country's efforts to promote scientific and technological innovation and to address the risk of key core technologies being "stuck", the medical device industry, as an industry also subject to constraints, also needs to take active measures to develop domestic technology with independent intellectual property rights.

  At this year's two sessions, two deputies to the National People's Congress put forward proposals for the development of medical devices.

  Representative Li Yan: Encourage biological product development and production enterprises to carry out domestic substitution

  Li Yan is the President of Qilu Pharmaceutical Group. As a leading figure in the domestic biomedical industry, Li Yan is prepared to submit a motion on insisting on innovation to vigorously promote the development of the biomedical industry at the two sessions this year. She believes that there are two main factors that restrict the further strengthening of China's biomedical industry: original innovation and key equipment.

  In order to change the status quo of the domestic pharmaceutical industry chain where imported products dominate the market of high-end instruments, equipment and consumables, Li Yan suggested that the R&D and production enterprises of biological products should be encouraged to carry out domestic substitution and change the bad culture of the domestic market which prefers imported products, so that when the quality of domestic products is comparable to that of imported products, domestic equipment can be preferred. At the same time, at the national level, policies and regulations should be adopted to support the replacement of domestic materials for products under development and on the market that use imported materials and equipment.

  Representative Zhou Yunjie: Broadening the application scenario of domestic medical devices

  As the President of Haier Group, Zhou Yunjie also has a clear understanding of the weakness of domestic medical devices in the market. He believes that the reason for this problem is that, compared to imported brands with deep technology and experience, and stable product quality, domestic brands have a lower level of technology, and their products are mainly ordinary and commonly used equipment, and have long served the market with small medical equipment, which do not have enough trust from hospitals and doctors.

  Zhou Yunjie also proposed to achieve "domestic substitution" in the field of high-end medical devices. Therefore, this year's proposal for the pharmaceutical industry is "Suggestions on Further Broadening the Application Scenario of Domestic Medical Devices". In the proposal, Zhou suggested that the state should accelerate the implementation of relevant special plans to expand the application of domestic medical devices; further enhance the awareness and recognition of domestic medical devices, and promote the realization of import substitution of domestic excellent medical devices. At the same time, the state should increase its financial investment to further support the research and development and technological upgrading of domestic medical devices.

  The medical device industry is a track with great development potential in the pharmaceutical industry, and there is still a significant gap between the overall technical level of medical devices in China and foreign countries. In the mid-range market domestic enterprises already have the ability to compete with imported products in some technologies, but in the high-end market with high technical barriers, the competitiveness of domestic enterprises is still very weak. There is still a long way to go if we want to achieve local substitution of medical equipment, and this requires more support from the state.